# High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade

> **NCT03162432** · PHASE3 · UNKNOWN · sponsor: **Boston Children's Hospital** · enrollment: 50 (estimated)

## Conditions studied

- IBD
- Ulcerative Colitis
- Crohn Disease

## Interventions

- **DRUG:** Vitamin D3

## Key facts

- **NCT ID:** NCT03162432
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03162432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03162432, "High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03162432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*